Comment on 'Endocrine therapy in prostate cancer: time for re-appraisal of risks, benefits and cost-effectiveness?'.
about
Comment on 'Endocrine therapy in prostate cancer: time for re-appraisal of risks, benefits and cost-effectiveness?'.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Comment on 'Endocrine therapy ...... fits and cost-effectiveness?'.
@en
Comment on 'Endocrine therapy ...... fits and cost-effectiveness?'.
@nl
type
label
Comment on 'Endocrine therapy ...... fits and cost-effectiveness?'.
@en
Comment on 'Endocrine therapy ...... fits and cost-effectiveness?'.
@nl
prefLabel
Comment on 'Endocrine therapy ...... fits and cost-effectiveness?'.
@en
Comment on 'Endocrine therapy ...... fits and cost-effectiveness?'.
@nl
P2093
P2860
P356
P1476
Comment on 'Endocrine therapy ...... fits and cost-effectiveness?'.
@en
P2093
F H Cafferty
R E Langley
S I A Shah
P2860
P2888
P304
P356
10.1038/BJC.2013.210
P407
P577
2013-04-30T00:00:00Z